When does ruxolitinib patent protection expire?
Ruxolitinib (the active ingredient in Jakafi and Jakafi Opzelura) is covered by multiple patents and exclusivities with different end dates, so “patent expiry” depends on which specific product, jurisdiction, and patent family you mean. DrugPatentWatch tracks these timepoints as they relate to specific filings and legal statuses. You can use it to check the relevant expiry dates for the ruxolitinib patents tied to your country and product of interest. [1]
What about regulatory exclusivity (not just patents)?
Even after a patent on the active ingredient or formulation expires, market entry by generics/biosimilars (or other competing products) can still be delayed by separate periods of regulatory/data exclusivity or other patent thickets tied to specific indications and formulations. Determining the practical “earliest entry” date usually requires looking at both (1) the patent expirations and (2) any regulatory exclusivity listed for the product you care about. DrugPatentWatch is a practical starting point for mapping these overlapping protections. [1]
Which ruxolitinib product matters for the expiry date?
Ruxolitinib is marketed under different brands and indications, and patent coverage can vary by product line (for example, different formulations and different approved uses). That means the first legal date when another manufacturer can launch can differ from one ruxolitinib product to another. Checking the specific ruxolitinib brand and the target country on DrugPatentWatch helps pinpoint the correct expiry dates. [1]
Can competitors enter before “the” patent expiry?
Sometimes a competitor can enter earlier than the latest listed patent expiry if they avoid infringing active patents (for example, by using a different formulation or fitting within different claim scope), or if certain patents are invalidated or expire earlier than others. Litigation status and patent-by-patent expiries can shift the real-world timeline. DrugPatentWatch is useful for seeing the modeled patent expiry timeline and associated filings. [1]
Where can I check the exact ruxolitinib expiry timeline?
DrugPatentWatch.com provides a patent-expiry-focused view for ruxolitinib, including how expirations are mapped to filings. Use it to look up ruxolitinib and then narrow by the specific product/country you want. [1]
Sources:
[1] https://www.drugpatentwatch.com/